Analysed CABALETTA BIO INC (CABA:NASDAQ) News Sources
Cabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual Meeting
14-05-2026
yahoo.com
Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Update
14-05-2026
yahoo.com
Pemphigus Vulgaris Market Analysis Report 2026-2036, Profiles of F. Hoffmann La Roche, Argenx, Sanofi, Syntimmune, Allmiral, Cabaletta Bio, and Novartis
21-05-2026
yahoo.com
Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress
03-06-2026
yahoo.com
Cabaletta Bio Inc. (CABA) A Top Penny Stock Eyeing Rese-Cel Commercial Launch for Autoimmune Diseases
07-06-2026
yahoo.com
How Cabaletta Bio (CABA) Is Turning Rese-cel Enrollment and New Financing Into a Clearer Autoimmune Cell Therapy Setup
17-06-2026
yahoo.com
What is the current price of CABALETTA BIO INC (CABA:NASDAQ)?
The current price of CABALETTA BIO INC (CABA:NASDAQ) is $2.71.
CABALETTA BIO INC (CABA:NASDAQ) absolute price change since previous trading day?
The absolute price change of CABALETTA BIO INC (CABA:NASDAQ) since the previous trading day is $-0.055.
CABALETTA BIO INC (CABA:NASDAQ) percentage price change since previous trading day?
The percentage price change of CABALETTA BIO INC (CABA:NASDAQ) since the previous trading day is -1.9892%.
What is the most recent average sentiment score for CABALETTA BIO INC (CABA:NASDAQ)?
The most recent average sentiment score for CABALETTA BIO INC (CABA:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for CABALETTA BIO INC (CABA:NASDAQ)?
The most recent sentiment for CABALETTA BIO INC (CABA:NASDAQ) is .
SEC-8K** Filing Available For CABALETTA BIO INC (CABA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.